News
U.S. FDA to approve mixing and matching of COVID vaccines
The FDA approved Pfizer and BioNTech booster shots in September to some high-risk Americans and those aged 65 and older
The Food and Drug Administration is planning on allowing people to receive a COVID vaccine booster shot that’s different to the one they initially received, according to The New York Times.
The government would not give preference to specific shots but doctors would still recommend receiving the same vaccine for all jabs when possible.
This has been prompted by recent findings on the “mix and match” study that were presented to the the expert advisory committee to the FDA.
The study showed that one dose of Johnson & Johnson followed by a Moderna booster saw antibody levels rise 76-fold in 15 days compared with only a fourfold increase after two doses of Johnson & Johnson.
Booster shots will soon be available to a wider range of Americans with the FDA to announce their recommendations on Wednesday.
Australia’s multimillion-dollar campaign to attract Hollywood productions to its shores appears to be paying off.
The allure of Australia lies not only in its picturesque locations but also in its competitive financial incentives.
The government offers generous rebates and tax breaks to international productions, making it an attractive proposition for filmmakers looking to maximise their budgets.
Despite the recent intake of Hollywood productions down under such as ‘The Fall Guy’ and ‘Furiosa: A Mad Max Saga’, Aussie independents are still finding the space to carve their own creative path.
Rob Fantozzi joined the program to discuss the latest in Hollywood, and showcased his own upcoming project – ‘Omerta‘. #featured
-
Shows3 days agoThe Dragon’s Tale
-
News5 days ago
Apple responds to crushing iPad Pro criticism
-
News3 days ago
Does American media have TikTok bias?
-
News2 days ago
U.S. home prices surge 47%
-
News2 days ago
Portal between countries shut down after international flashing
-
News4 days ago
European elections loom: the rise of the far-right
-
Money5 days ago
Why the meme-stock frenzy is unlikely to repeat
-
News4 days ago
Will the U.S. approve MDMA therapy?
